Boston Scientific

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Boston Scientific 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About BSX

Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. It operates through the MedSurg and Cardiovascular segments. 

CEO
Michael F. Mahoney
CEOMichael F. Mahoney
Employees
59,000
Employees59,000
Headquarters
Marlborough, Massachusetts
HeadquartersMarlborough, Massachusetts
Founded
1979
Founded1979
Employees
59,000
Employees59,000

BSX Key Statistics

Market cap
60.82B
Market cap60.82B
Price-Earnings ratio
17.78
Price-Earnings ratio17.78
Dividend yield
—
Dividend yield—
Average volume
22.15M
Average volume22.15M
High today
$43.28
High today$43.28
Low today
$41.73
Low today$41.73
Open price
$43.14
Open price$43.14
Volume
22.47M
Volume22.47M
52 Week high
$105.65
52 Week high$105.65
52 Week low
$39.57
52 Week low$39.57

Stock Snapshot

As of today, Boston Scientific(BSX) shares are valued at $42.00. The company's market cap stands at 60.82B, with a P/E ratio of 17.78.

On 2026-10-31, Boston Scientific(BSX) stock moved within a range of $41.73 to $43.28. With shares now at $42.00, the stock is trading +0.7% above its intraday low and -3.0% below the session's peak.

Trading activity shows a volume of 22.47M, compared to an average daily volume of 22.15M.

The stock's 52-week range extends from a low of $39.57 to a high of $105.65.

The stock's 52-week range extends from a low of $39.57 to a high of $105.65.

BSX News

Zacks 1d
New Strong Sell Stocks for October 30th

Here are three stocks added to the Zacks Rank #5 (Strong Sell) List today: Boston Scientific Corporation (BSX Quick QuoteBSX - Free Report) is a medical...

New Strong Sell Stocks for October 30th
Simply Wall St 1d
Cyberattack Disruption Might Change The Case For Investing In Boston Scientific

Boston Scientific reported Q3 2026 results with US$5.14b in sales and US$582m in net income, while also recording US$39m of goodwill and intangible asset impair...

Benzinga 2d
These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results

Boston Scientific Corp (NYSE:BSX) on Wednesday posted upbeat third-quarter financial results and cut its FY26 guidance below estimates. The company reported Q3...

These Analysts Revise Their Forecasts On Boston Scientific After Q3 Results

Analyst ratings

68%

of 34 ratings
Buy
67.6%
Hold
32.4%
Sell
0%

More BSX News

The Motley Fool 2d
Boston Scientific: 3 Key Takeaways for Long-Term Investors

On its third-quarter 2026 earnings call, held on Oct. 28, 2026, Boston Scientific (BSX -5.84%) announced that a recent cyber incident and headwinds in key produ...

Boston Scientific: 3 Key Takeaways for Long-Term Investors
TipRanks 2d
Boston Scientific Faces Earnings Strain Amid Cyber Shock

Boston Scientific ((BSX)) has held its Q3 earnings call. Read on for the main highlights of the call. Boston Scientific’s latest earnings call struck a cautiou...

The Motley Fool 3d
Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact

BSX - Boston Scientific $42.43 -$2.63 (-5.84%) NYSE · As of 4:00 PM ET 10/28/26 Premium Feature Moneyball Superscore 78 /100 Key data points Market cap Market c...

Stock Market Today, Oct. 28: Boston Scientific Slips 6% After Cutting Q4 Sales and Full-Year EPS Guidance on Cyberattack Impact
Seeking Alpha 3d
Boston Scientific downgraded at JP Morgan as new negatives to impact shares

JP Morgan downgraded Boston Scientific (BSX) to neutral from overweight on Wednesday, saying the medical device company is facing several new negative factors t...

Boston Scientific downgraded at JP Morgan as new negatives to impact shares
Benzinga 3d
Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance

Boston Scientific Corporation (NYSE:BSX) stock is trading lower on Wednesday after the company issued a weaker-than-expected earnings outlook. CEO Mike Mahoney...

Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance
Investor's Business Daily 3d
Boston Scientific Crashes 11% As Cybersecurity Attack Weighs On Guide

Boston Scientific Slammed After Cyberattack Hamstrings Sales, Profit 9/08/2026 Boston Scientific said Tuesday a cybersecurity incident is likely to have a mate...

Boston Scientific Crashes 11% As Cybersecurity Attack Weighs On Guide
Zacks 3d
Compared to Estimates, Boston Scientific Q3 Earnings: A Look at Key Metrics

Boston Scientific (BSX Quick QuoteBSX - Free Report) reported $5.14 billion in revenue for the quarter ended September 2026, representing a year-over-year...

Compared to Estimates, Boston Scientific Q3 Earnings: A Look at Key Metrics

People also own

Based on the portfolios of people who own BSX. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.